Ductal carcinoma in situ: Clinical perspective

Breast Care

Volumn 5, Issue 4, 2010, Pages 227-232

  Kühn, Thorsten ^a  

^a KLINIKUM ESSLINGEN   (Germany)

Author keywords

Breast cancer; Ductal carcinoma in situ; Radiotherapy; Surgery; Tamoxifen

Indexed keywords

TAMOXIFEN;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EDEMA; HOT FLUSH; HUMAN; INTRADUCTAL CARCINOMA; MASTECTOMY; MENSTRUATION DISORDER; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBOEMBOLISM; TREATMENT PLANNING; VAGINA DISCHARGE;

EID: 77957066938     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000319325     Document Type: Review

References (34)

1. Frykberg ER, Bland KI: Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 1194;74:350-361.
2. Rosen PP, Braun DW, Kinne DE: The clinical significance of preinvasive breast carcinoma. Cancer 1980;46:919-925.
3. Eusebi V, Feudale E, Foschini MP, et al.: Longterm follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994;11:223-235.
4. Caus EB, Sowe M, Carter D: Breast carcinoma in situ: risk factors and screening patterns J Natl Cancer Inst 2001;93:1811-1817.
5. Jemal A, Siegel R, Ward E: Cancer Statistics 2007. CA Cancer J Clin 2007;57:43.
6. Rosner D, Bedwani RN, Vana J, et al.: Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139.
7. Ernster VL, Barclay J, Kerlikowske K, et al.: Mortality among women with ductal carcinoma in situ of the breast in the population based surveillance, epidemiology and end results program. Arch Intern Med 2000;160:953-958.
8. Solin LJ, Kurtz J, Fourquet A, et al.: Fifteen-year results of breast-conserving surgery and definite breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 2000;14:754-763.
9. Kuhl CK, Schrading S, Bieling HB, et al.: MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007;370:485-492.
10. Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, DOrsi C, Sickles E, Burhenne LW: Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, MRI, breast ultrasound and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010;7:18-27.
11. Allen LR, Lago-Toro CE, Hughes JH, Careaga E, Brown AT, Chernick M, Barrio AV, Frazier TG: Is there a role of MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol 2010;Epub ahead of print.
12. Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburin WJ: The influence of margin width on local control of ductal carcinoma in situof the breast. N Engl J Med 1999;340:1455-1461.
13. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Fisher B, Paik S, et al.: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-452.
14. Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Genaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJT: Breast conserving treatment with or without radiotherapy in ductal carcinoma in situ: ten year results of European Organisation for Research and Treatment of Cancer Randomized Phase trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy group. J Clin Oncol 2006;24:3381-3387.
15. Goodwin A, Parker S, Ghersi D, Wilcken N: Postoperative radiotherapy for ductal carcinoma in situ of the breast - a systematic review of the randomized trials. Breast 2009;18:143-149.
16. Cuzik J, Sestak I, Pinder SE, Ellis IO, Hackshaw A, bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD: Beneficial effect of tamoxifen for women with DCIS: long-term results from the UK/ANZ DCIS trial in women with locally excised DCIS. Cancer Res 2009;69(suppl):34.
17. Allred DC, Bryant J, Land S, et al.: Estrogen receptor expression as a predictive marker of the effectiveness of tamoxifen in the treatment of DCIS: findings from NSABP protocol B-24. Breast Cancer Res Treat 2002;76:36.
18. Silverstein MJ, Barth A, Poller DN: Ten year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31A:1425-1427.
19. Shouten van der Velden AP, van Vugt R, Van Dijck JA, et al.: Local recurrences after different treatment strategies for ductal carcinoma of the beast: a population based study in the East Netherlands. Int J Radiat Oncol Biol Phys 2007;69:703-710.
20. Faverly DR, Burgers L, Bult P, Holland R: Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193.
21. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittel M, et al.: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia and New Zealand: a randomized controlled trial. Lancet 2003;362:95-102.
22. Holmberg L, Garmo H, Granstrand B, Ringberg A, Arnesson LG, Sandelin K, et al.: Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 2008;26:1247-1252.
23. Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 2006;24:1031-1036.
24. Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, Lowen LA, Ingle JN, Recht A, Wood WC: Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27:5319,5324.
25. Dunne C, Burke JP, Morrow M, Kell MR: Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009;27:1615-2160
26. Winchester DP, Menck HR, Osteen RT, Kraybill W: Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol 1995;2:207.
27. Inta M, Veronesi P, Mazzarol G, et al.: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309.
28. Julian TB, Land SR, Fourchote V, et al.: Is sentinel node biopsy necessary in conservatively treated DCIS? Ann Surg Oncol 2007;23:7703.
29. Kühn T, Bembenek A, Decker T, Munz DL, Sautter- Bihl ML, Untch M, Wallwiener D: Consensus Committee of the German Society of Senology. A concept for the clinical implementation of sentinel lymph node biopsy (SLNB) in breast cancer patients with special regard to quality assurance. Cancer 2005;103:451-461.
30. Fisher B, Dignan J, Wolmark N, Wickerman DL, Fisher ER, Mamounas E, Smith R, Beqovic M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher L, Oishi RH: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:1993-2000.
31. UK Coordinating Committee on Cancer Research (UKCCCR): Ductal carcinoma in situ (DCIS) working party on behalf of DCIS trialists in the UK, Australia and New Zealand. Lancet 2003;362:95-102.
32. Early Breast Cancer Trialists Collaborative Group (EBCTCG): Effect of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrences and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-2106.
33. Early Breast Cancer Trialists Collaborative Group (EBCTCG): Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-1717.
34. Jeruss JS, Vicini FA, Beitsch PD, et al.: Initial outcomes for patients treated on the American Society of Breast Surgeons Mammosite clinical trial for ductal carcinoma in situ of the breast. Ann Surg Oncol 2006;13:967-976.